Acetaminophen; propoxyphene napsylate - Generic Drug Details

What are the generic drug sources for acetaminophen; propoxyphene napsylate and what is the scope of patent protection?

Acetaminophen; propoxyphene napsylate is the generic ingredient in five branded drugs marketed by Xanodyne Pharm, Teva, Able, Actavis Elizabeth, Cornerstone, Halsey, Ivax Sub Teva Pharms, Mallinckrodt, Mirror Pharms, Mutual Pharm, Mylan, Mylan Pharms Inc, Sandoz, Superpharm, Vintage Pharms, Watson Labs, Watson Labs Florida, and Wockhardt Ltd, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

Summary for acetaminophen; propoxyphene napsylate

US Patents:	0
Tradenames:	5
Applicants:	18
NDAs:	29
DailyMed Link:	acetaminophen; propoxyphene napsylate at DailyMed

US Patents and Regulatory Information for acetaminophen; propoxyphene napsylate

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mallinckrodt	PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN	acetaminophen; propoxyphene napsylate	TABLET;ORAL	075738-001	Feb 2, 2001		DISCN	No	No
Superpharm	PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN	acetaminophen; propoxyphene napsylate	TABLET;ORAL	071319-001	Jan 6, 1987		DISCN	No	No
Cornerstone	PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN	acetaminophen; propoxyphene napsylate	TABLET;ORAL	076743-001	May 7, 2004		DISCN	No	No
Mylan	PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN	acetaminophen; propoxyphene napsylate	TABLET;ORAL	072195-001	Feb 16, 1988		DISCN	No	No
Teva	PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN	acetaminophen; propoxyphene napsylate	TABLET;ORAL	074119-001	Dec 19, 1994		DISCN	No	No